JUNS
JUNS
NASDAQ · Pharmaceuticals

Jupiter Neurosciences Inc

$5.10
-0.53 (-9.45%)
As of Aug 8, 10:53 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +761.4% upside
Low Target $31.75
Average Target $43.93
High Target $69.04
Current Price $5.10
Current
$5.10
Target
$43.93
$31.75 $43.93 avg $69.04
Scenario Analysis
Bear Case
$31.75
522.5%
Low target
Base Case
$43.93
+761.4%
Avg target
Bull Case
$69.04
+1,253.7%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$1.84
177.2% from high
52-Week Low
$0.07
+7,083.1% from low
Target vs 52W High
$43.93
+2,287.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%